Draganfly, Inc. (NASDAQ: DPRO) (CSE: DPRO) is engaged within the research, development, and sale of innovative drone technologies, software, and artificial intelligence systems. Shares of the drone company are soaring 90% through early trading on Tuesday, March 22, 2022. Over the past three months, Draganfly has seen average daily volume of around 211,570 shares. However, volume of 119.91 million shares or dollar volume of around $378.92 million, has already exchanged hands through early trading.
Shares of Draganfly are surging after the company announced that it has received a purchase order for its Medical Response and Search & Rescue drones from Coldchain Delivery Systems, LLC. The drones are set for immediate deployment to Ukraine with Revived Soldiers Ukraine (RSU).
The initial order will send ten of the critical lifesaving drones and Draganfly has earmarked an additional three drone systems for donation. The total initial order size is up to 200 units, subject to conditions.
Made in North America, Draganfly’s Medical Response and Search & Rescue drones are equipped with a temperature-controlled “Medical Response Payload Box,” which can hold up to 35 pounds of medical supplies, blood, pharmaceuticals, wound care kits, water, vaccines, and more.
The RSU is a Ukrainian non-profit organization founded in 2015 and dedicated to provide aid and assistance to the people of Ukraine. The organization’s current focus is to send medical supplies and care to wounded soldiers fighting the Russian invasion. To date, the RSU has allocated over $19 million in supplies to Ukrainian citizens and hospitals.
Cameron Chell, CEO of Draganfly: “We are extremely honored to work with RSU and Coldchain Delivery Systems to support those affected by the ongoing crisis in Ukraine. Draganfly has a long and proud history of supporting EMS services and humanitarian aid operations globally. Our Medical Response and Search and Rescue Drones will help RSU deliver critical supplies, equipment, and visual oversight.”
Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/
